126 related articles for article (PubMed ID: 9761018)
1. Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack.
Oosaki R; Mizushima Y; Kawasaki A; Mita H; Akiyama K; Kobayashi M
Clin Exp Allergy; 1998 Sep; 28(9):1138-44. PubMed ID: 9761018
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
Severien C; Artlich A; Jonas S; Becher G
Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks.
Oosaki R; Mizushima Y; Kawasaki A; Kashii T; Mita H; Shida T; Akiyama K; Kobayashi M
Int Arch Allergy Immunol; 1997 Dec; 114(4):373-8. PubMed ID: 9414142
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
[TBL] [Abstract][Full Text] [Related]
5. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma.
Oosaki R; Mizushima Y; Mita H; Shida T; Akiyama K; Kobayashi M
Allergy; 1997 Apr; 52(4):470-3. PubMed ID: 9188934
[TBL] [Abstract][Full Text] [Related]
6. [A fundamental study on clinical significance of measuring eosinophil protein X in spot urine in asthmatics].
Oosaki R; Mizushima Y; Kawasaki A; Fujishita T; Kawagishi Y; Mita H; Akiyama K; Kobayashi M
Arerugi; 1998 Dec; 47(12):1273-9. PubMed ID: 10028722
[TBL] [Abstract][Full Text] [Related]
7. Time-course study of the levels of urinary leukotriene E4, serum thromboxane B2 and serum eosinophil cationic protein in spontaneous asthma attacks in five children.
Inoue R; Fukao T; Kato Y; Teramoto T; Utsumi M; Kondo N
J Investig Allergol Clin Immunol; 1999; 9(6):361-6. PubMed ID: 10664930
[TBL] [Abstract][Full Text] [Related]
8. Circadian variation of urinary eosinophil protein X in asthmatic and healthy children.
Storm van's Gravesande K; Mattes J; Grüntjens T; Kopp M; Seydewitz HH; Moseler M; Kuehr J
Clin Exp Allergy; 1999 Nov; 29(11):1497-501. PubMed ID: 10520077
[TBL] [Abstract][Full Text] [Related]
9. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment.
Kristjánsson S; Strannegård IL; Strannegård O; Peterson C; Enander I; Wennergren G
J Allergy Clin Immunol; 1996 Jun; 97(6):1179-87. PubMed ID: 8648010
[TBL] [Abstract][Full Text] [Related]
10. Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients.
Suzuki N; Hishinuma T; Abe F; Omata K; Ito S; Sugiyama M; Mizugaki M
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):395-403. PubMed ID: 11060902
[TBL] [Abstract][Full Text] [Related]
11. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
12. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
13. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?
Koller DY; Halmerbauer G; Frischer T; Roithner B
Clin Exp Allergy; 1999 Jun; 29(6):786-93. PubMed ID: 10336595
[TBL] [Abstract][Full Text] [Related]
14. Asthma attack severity and urinary concentration of eosinophil X protein in children.
Khalil Kalaajieh W; Hoilat R
Allergol Immunopathol (Madr); 2002; 30(4):225-31. PubMed ID: 12199967
[TBL] [Abstract][Full Text] [Related]
15. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study.
Wojnarowski C; Roithner B; Koller DY; Halmerbauer G; Gartner C; Tauber E; Frischer T
Clin Exp Allergy; 1999 Jul; 29(7):926-32. PubMed ID: 10383593
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
Mita H; Endoh S; Kudoh M; Kawagishi Y; Kobayashi M; Taniguchi M; Akiyama K
Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
[TBL] [Abstract][Full Text] [Related]
17. Urinary leukotriene E(4), eosinophil protein X, and nasal eosinophil cationic protein are not associated with respiratory symptoms in 1-year-old children.
Wojnarowski C; Halmerbauer G; Mayatepek E; Gartner C; Frischer T; Forster J; Kuehr J;
Allergy; 2001 Sep; 56(9):883-8. PubMed ID: 11551254
[TBL] [Abstract][Full Text] [Related]
18. Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough.
Labbé A; Aublet-Cuvelier B; Jouaville L; Beaugeon G; Fiani L; Petit I; Ouchchane L; Doly M
Pediatr Pulmonol; 2001 May; 31(5):354-62. PubMed ID: 11340681
[TBL] [Abstract][Full Text] [Related]
19. Urinary eosinophil protein X in children with asthma: influence of atopy and airway infections.
Oymar K; Bjerknes R
Pediatr Allergy Immunol; 2001 Feb; 12(1):34-41. PubMed ID: 11251863
[TBL] [Abstract][Full Text] [Related]
20. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
